SEC Form 4 · accession 0001179110-16-027392
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Carchedi
Director
Period of report
Jun 30, 2016
Accepted (ET)
Jul 5, 2016 · 6:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.5477 | Jun 30, 2016 | A | 50,000 | A | — | Jun 30, 2026 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1Vests over one (1) year in equal monthly installments from the date of grant.